SHPPF:OTC-Shop Apotheke Europe N.V (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 161.1033

Change

0.00 (0.00)%

Market Cap

USD 3.23B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 12.16B
JDHIF JD Health International Inc

N/A

USD 9.97B
ALBHF Alibaba Health Information Tec..

N/A

USD 8.27B
RADLY Raia Drogasil SA ADR

-0.29 (-5.87%)

USD 7.74B
CLCGY Clicks Group Ltd

+0.63 (+1.50%)

USD 5.11B
SAEYY Shop Apotheke Europe N.V

N/A

USD 3.16B
NOTR Nowtransit Inc

N/A

USD 0.55B
ZRSEF Zur Rose Group AG

-3.47 (-8.17%)

USD 0.54B
NVACF Nova Cannabis Inc

N/A

USD 0.08B
PNPL Pineapple Express

N/A

USD 0.01B

ETFs Containing SHPPF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 238.10% 88% B+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 238.10% 88% B+ 90% A-
Trailing 12 Months  
Capital Gain 238.10% 88% B+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 238.10% 88% B+ 90% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.59% 56% F 58% F
Dividend Return 13.59% 56% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 90.44% 52% F 36% F
Risk Adjusted Return 15.03% 56% F 48% F
Market Capitalization 3.23B 76% C+ 83% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.